| Literature DB >> 25789881 |
Graciela Chaves1, Nidia Britez1, Judith Munzinger2, Lorenz Uhlmann2, Graciela Gonzalez1, Guillermo Oviedo1, Victoria Chaparro1, Oscar Achon1, Thomas Bruckner2, Meinhard Kieser2, Hugo A Katus3, Derliz Mereles3.
Abstract
BACKGROUND: Cardiovascular diseases are the current leading causes of death and disability globally.Entities:
Mesh:
Substances:
Year: 2015 PMID: 25789881 PMCID: PMC4495449 DOI: 10.5935/abc.20150021
Source DB: PubMed Journal: Arq Bras Cardiol ISSN: 0066-782X Impact factor: 2.000
Baseline of the study population
| n | 15,073 | |
| Age, yrs | 50.8 ± 15.1 | |
| Women, n (%) | 10,377 (69) | |
| Weight, kg | 77.3 ± 16.0 | |
| Body mass index, n (%) | ||
| < 25 kg/m2 | 2,966 (19.7) | |
| 25-29 kg/m2 | 5,583 (37.0) | |
| > 30 kg/m2 | 6,524 (43.3) | |
| Personal history of CAD, n (%) | 390 (2.6) | |
| Known diabetes mellitus, n (%) | 2,063 (13.7) | |
| Family history of CAD, n (%) | 819 (5.4) | |
| Symptoms | ||
| Dyspnea, n (%) | 5,221 (34.7) | |
| NYHA I | 527 (3.5) | |
| NYHA II | 2,743 (18.2) | |
| NYHA III | 1,951 (12.9) | |
| Angina pectoris, n (%) | 2,388 (15.8) | |
| CCS I | 407 (2.7) | |
| CCS II | 1,271 (8.4) | |
| CCS III | 710 (4.7) | |
Values are expressed as mean ± SD. Data for categorical variables are shown as the number of cases with percentages in brackets. CAD: coronary artery disease; NYHA: New York Heart Association functional classification; CCS: Canadian Cardiovascular Society angina classification. Numbers of missing values smaller than or equal to ten are not reported.
Figure 1Flow of participants during the study. Only the first 5 visits considered for dropout analysis are shown here. Changes in parameters were analyzed between the first and second assessments.
Changes in parameters at the second assessment after education to a healthy lifestyle (n = 3,009)
| Weight, kg | 76.6 ± 15.3 | 76.4 ± 15.3 | 0.002 | ||
| Body mass index, kg/m2 | 30.2 ± 5.6 | 30.1 ± 5.6 | 0.004 | ||
| Symptoms | |||||
| Dyspnea, n (%) | |||||
| No | 1,699 (56.6) | 1,843 (61.3) | |||
| Yes | 1,310 (43.5) | 1,164 (38.7) | < 0.001 | ||
| NYHA I | 131 (4.4) | 111 (3.7) | |||
| NYHA II | 705 (23.4) | 632 (21.0) | |||
| NYHA III | 474 (15.8) | 421 (14.0) | |||
| Angina pectoris, n (%) | |||||
| No | 2,547 (84.6) | 2,580 (85.8) | |||
| Yes | 462 (15.4) | 428 (14.2) | 0.143 | ||
| CCS I | 77 (2.6) | 69 (2.3) | |||
| CCS II | 231 (7.7) | 224 (7.4) | |||
| CCS III | 154 (5.1) | 135 (4.5) | |||
| Smoking, n (%) | |||||
| Current smoker | |||||
| No | 2,110 (70.1) | 2,129 (70.8) | |||
| Yes | 899 (29.9) | 880 (29.2) | 0.110 | ||
| Active | |||||
| No | 2,900 (96.4) | 2,923 (97.1) | |||
| Yes | 109 (3.6) | 86 (2.9) | 0.002 | ||
| Passive | |||||
| No | 2,196 (73.0) | 2,199 (73.1) | |||
| Yes | 813 (27.0) | 810 (26.9) | 0.772 | ||
| Former smoker | |||||
| No | 2,343 (77.9) | 2,309 (76.7) | |||
| Yes | 666 (22.1) | 700 (23.3) | < 0.001 | ||
| Diet, n (%) | |||||
| Poor | 983 (32.7) | 690 (22.9) | < 0.001 | ||
| Intermediate | 1,785 (59.3) | 1,901 (63.2) | |||
| Ideal | 241 (8.0) | 417 (13.9) | |||
| Physical activity, n (%) | |||||
| No | 1,626 (54.0) | 1,478 (49.2) | < 0.001 | ||
| Some | 1,378 (45.8) | 1,519 (50.5) | |||
| Frequent | 5 (0.2) | 9 (0.3) | |||
| Psychological stress level, n (%) | |||||
| Mild or absent | 604 (42.1) | 453 (46.5) | 0.006 | ||
| Moderate | 646 (45.0) | 391 (40.1) | |||
| Important | 185 (12.9) | 131 (13.4) | |||
| Missing | 1,574 | 2,034 | |||
Values are expressed as mean ± SD. Data for categorical variables are shown as the number of cases with percentages in brackets. NYHA: New York Heart Association functional classification; CCS: Canadian Cardiovascular Society angina classification. Changes in dietary intake are depicted on Table 4. P values were calculated using the t test *, the McNemar's test † for symmetry and the Bowker's test ‡ for symmetry, as required. Numbers of missing values smaller than four are not reported.
Changes in the prevalence of ATP III parameters for metabolic syndrome and LDL cholesterol in participants at the second assessment after education for a healthy lifestyle (n = 3,009)
| Variable | Baseline | Second Assessment | P value | ||
|---|---|---|---|---|---|
| Waist circumference | |||||
| Women > 88 cm, n (%) | 1,824 (79.6) | 1,827 (79.7) | 0.845 | ||
| Men > 102 cm, n (%) | 302 (42.1) | 299 (41.7) | 0.763 | ||
| Triglycerides > 150 mg/dL, n (%) | 1,382 (46.3) | 1,268 (42.4) | < 0.001 | ||
| Missing | 26 | 21 | |||
| HDL cholesterol | |||||
| Women < 50 mg/dL, n (%) | 978 (43.6) | 1,018 (45.2) | 0.250 | ||
| Missing | 50 | 38 | |||
| Men < 40 mg/dL, n (%) | 187 (26.7) | 175 (24.9) | 0.280 | ||
| Missing | 16 | 15 | |||
| Blood pressure | |||||
| Systolic > 130 mmHg, n (%) | 1,352 (44.9) | 1,318 (43.8) | 0.279 | ||
| Diastolic > 85 mmHg, n (%) | 941 (31.3) | 913 (30.3) | 0.362 | ||
| Fasting glucose > 100mg/dL, n (%) | 591 (19.8) | 603 (20.2) | 0.492 | ||
| Missing | 23 | 24 | |||
| LDL cholesterol > 100 mg/dL, n (%) | 2,039 (69.3) | 1,937 (65.5) | < 0.001 | ||
| Missing | 66 | 53 | |||
Data are presented as the number of cases with percentages in brackets. ATP III: Adult Treatment Panel III (Third Report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults), HDL: high-density lipoprotein; LDL: low-density lipoprotein. P values were calculated using the McNemar's test for symmetry. Numbers of missing values smaller than four are not reported.
Changes in prevalence of parameters of AHA 2020 cardiovascular health metrics after education for a healthy lifestyle (n = 3,009)
| Variable | Baseline | Second Assessment | % Change | P value | |
|---|---|---|---|---|---|
| Smoking | |||||
| Poor | 109 (3.6) | 86 (2.9) | -21.1 | < 0.001 | |
| Intermediate | 32 (1.1) | 28 (0.9) | -12.5 | ||
| Ideal | 2,868 (95.3) | 2,893 (96.2) | 0.9 | ||
| Diet | |||||
| Poor | 983 (32.7) | 690 (22.9) | -29.8 | < 0.001 | |
| Intermediate | 1,785 (59.3) | 1,901 (63.2) | 6.5 | ||
| Ideal | 241 (8.0) | 417 (13.9) | 73.0 | ||
| Physical activity | |||||
| Poor | 1,626 (54.0) | 1,478 (49.2) | -9.1 | < 0.001 | |
| Intermediate | 1,378 (45.8) | 1,519 (50.5) | 10.2 | ||
| Ideal | 5 (0.2) | 9 (0.3) | 80.0 | ||
| Body weight | |||||
| Poor | 1,376 (45.7) | 1,356 (45.1) | -1.5 | 0.323 | |
| Intermediate | 1,166 (38.8) | 1,171 (38.9) | 0.4 | ||
| Ideal | 467 (15.5) | 481 (16.0) | 3.0 | ||
| Glucose | |||||
| Poor | 317 (10.6) | 303 (10.2) | -4.4 | 0.046 | |
| Intermediate | 704 (23.6) | 745 (25.0) | 5.8 | ||
| Ideal | 1,965 (65.8) | 1,937 (64.9) | -1.4 | ||
| Missing | 23 | 24 | |||
| Cholesterol | |||||
| Poor | 674 (22.6) | 515 (17.2) | -23.6 | < 0.001 | |
| Intermediate | 935 (31.3) | 900 (30.1) | -3.7 | ||
| Ideal | 1,377 (46.1) | 1,574 (52.7) | 14.3 | ||
| Missing | 23 | 20 | |||
| Blood pressure | |||||
| Poor | 1,187 (39.4) | 1,131 (37.6) | -4.7 | 0.348 | |
| Intermediate | 1,185 (39.4) | 1,233 (41.0) | 4.1 | ||
| Ideal | 637 (21.2) | 645 (21.4) | 1.3 | ||
Data are presented as the number of participants with percentages in brackets. P values were calculated using the Bowker's test for symmetry. AHA 2020: American Heart Association's 2020 Strategic Impact Goals.